Eric A. Rose
#162,069
Most Influential Person Now
Eric A. Rose's AcademicInfluence.com Rankings
Eric A. Roseengineering Degrees
Engineering
#7022
World Rank
#8381
Historical Rank
Biomedical Engineering
#671
World Rank
#683
Historical Rank
Eric A. Rosephilosophy Degrees
Philosophy
#9378
World Rank
#12930
Historical Rank
Logic
#6358
World Rank
#7870
Historical Rank
Download Badge
Engineering Philosophy
Eric A. Rose's Degrees
- Doctorate Medicine Harvard University
Why Is Eric A. Rose Influential?
(Suggest an Edit or Addition)Eric A. Rose's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Long-term use of a left ventricular assist device for end-stage heart failure. (2001) (3420)
- Long-term outcomes of coronary-artery bypass grafting versus stent implantation. (2005) (685)
- Two-Year Outcomes of Surgical Treatment of Moderate Ischemic Mitral Regurgitation. (2016) (610)
- Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders. (1995) (526)
- Reversal of chronic ventricular dilation in patients with end-stage cardiomyopathy by prolonged mechanical unloading. (1995) (432)
- Low incidence of myocardial recovery after left ventricular assist device implantation in patients with chronic heart failure. (1998) (426)
- Selection and treatment of candidates for heart transplantation. A statement for health professionals from the Committee on Heart Failure and Cardiac Transplantation of the Council on Clinical Cardiology, American Heart Association. (1995) (422)
- Multicenter clinical evaluation of the HeartMate 1000 IP left ventricular assist device. (1992) (399)
- Management of vasodilatory shock after cardiac surgery: identification of predisposing factors and use of a novel pressor agent. (1998) (360)
- Implantable left ventricular assist devices. (1998) (354)
- The REMATCH trial: rationale, design, and end points. Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure. (1999) (349)
- Persistent allopeptide reactivity and epitope spreading in chronic rejection of organ allografts. (1998) (336)
- Surgical ablation of atrial fibrillation during mitral-valve surgery. (2015) (334)
- Improved Mortality and Rehabilitation of Transplant Candidates Treated with a Long‐Term Implantable Left Ventricular Assist System (1995) (333)
- Anesthesia with abdominal surgery leads to intense REM sleep during the first postoperative week. (1990) (314)
- Multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system in patients awaiting heart transplantation. (2001) (310)
- Multicenter clinical evaluation of the heartmate; vented electric left ventricular assist system in patients awaiting heart transplantation. (2001) (290)
- American Surgical Association Blue Ribbon Committee Report on Surgical Education: 2004. (2005) (287)
- Left ventricular assist devices as destination therapy: a new look at survival. (2005) (285)
- Indirect recognition of donor HLA-DR peptides in organ allograft rejection. (1996) (259)
- Surgical treatment of moderate ischemic mitral regurgitation. (2014) (237)
- A prospective randomized trial of arginine vasopressin in the treatment of vasodilatory shock after left ventricular assist device placement. (1997) (233)
- Bridge experience with long-term implantable left ventricular assist devices. Are they an alternative to transplantation? (1997) (224)
- Randomized, double-blind trial of inhaled nitric oxide in LVAD recipients with pulmonary hypertension. (1998) (224)
- Prospective, Multicenter Study of Ventricular Assist Device Infections (2013) (217)
- Multicenter review of preoperative risk factors for stroke after coronary artery bypass grafting. (2000) (212)
- Management of heart failure. III. The role of revascularization in the treatment of patients with moderate or severe left ventricular systolic dysfunction. (1994) (208)
- Do Hospitals and Surgeons With Higher Coronary Artery Bypass Graft Surgery Volumes Still Have Lower Risk-Adjusted Mortality Rates? (2003) (205)
- The role of anti-HLA antibodies in heart transplantation. (1991) (201)
- Screening scale predicts patients successfully receiving long-term implantable left ventricular assist devices. (1995) (186)
- Activation-induced T-cell death and immune dysfunction after implantation of left-ventricular assist de vice (1999) (173)
- Predicting recurrent mitral regurgitation after mitral valve repair for severe ischemic mitral regurgitation. (2015) (171)
- Elevated pulmonary vascular resistance and cardiac transplantation. (1987) (163)
- Cardiac transplantation: recipient selection, donor procurement, and medical follow-up. A statement for health professionals from the Committee on Cardiac Transplantation of the Council on Clinical Cardiology, American Heart Association. (1992) (155)
- Activation of coagulation and fibrinolytic pathways in patients with left ventricular assist devices. (1996) (155)
- Reevaluating the significance of pulmonary hypertension before cardiac transplantation: determination of optimal thresholds and quantification of the effect of reversibility on perioperative mortality. (1997) (155)
- A comparison of short- and long-term outcomes after off-pump and on-pump coronary artery bypass graft surgery with sternotomy. (2004) (149)
- Preformed IgG antibodies against major histocompatibility complex class II antigens are major risk factors for high-grade cellular rejection in recipients of heart transplantation. (1998) (149)
- The influence of infection on survival and successful transplantation in patients with left ventricular assist devices. (1997) (147)
- Malignant ventricular arrhythmias are well tolerated in patients receiving long-term left ventricular assist devices. (1994) (140)
- Mesenchymal Precursor Cells as Adjunctive Therapy in Recipients of Contemporary Left Ventricular Assist Devices (2014) (137)
- Low thromboembolic risk without anticoagulation using advanced-design left ventricular assist devices. (1996) (135)
- 100 long-term implantable left ventricular assist devices: the Columbia Presbyterian interim experience. (1999) (135)
- Immunologic sensitization in recipients of left ventricular assist devices. (2003) (134)
- Artificial circulatory support with textured interior surfaces. A counterintuitive approach to minimizing thromboembolism. (1994) (134)
- A randomized double-blind study of the effect of triiodothyronine on cardiac function and morbidity after coronary bypass surgery. (1999) (131)
- Heart reduction surgery: an analysis of the impact on cardiac function. (1997) (130)
- Use of aprotinin in LVAD recipients reduces blood loss, blood use, and perioperative mortality. (1995) (128)
- Characterization of hematopoietic cells arising on the textured surface of left ventricular assist devices. (1995) (127)
- Intravenous immunoglobulin reduces anti-HLA alloreactivity and shortens waiting time to cardiac transplantation in highly sensitized left ventricular assist device recipients. (1999) (127)
- Left ventricular assist devices: bridges to transplantation, recovery, and destination for whom? (2003) (123)
- Experience with right ventricular assist devices for perioperative right-sided circulatory failure. (1996) (121)
- Management practices and major infections after cardiac surgery. (2014) (121)
- Left Ventricular Assist Devices as Permanent Heart Failure Therapy: The Price of Progress (2003) (120)
- Preparation of fibrin glue from single-donor fresh-frozen plasma. (1985) (119)
- Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders (1995) (114)
- Humoral immune responses after cardiac transplantation: correlation with fatal rejection and graft atherosclerosis. (1989) (112)
- Implantable left ventricular assist devices provide an excellent outpatient bridge to transplantation and recovery. (1997) (112)
- Relation of HLA antibodies and graft atherosclerosis in human cardiac allograft recipients. (1992) (109)
- Long-term survivors of pediatric heart transplantation: a multicenter report of sixty-eight children who have survived longer than five years. (1997) (107)
- The Effect of Body Mass Index on Survival Following Heart Transplantation: Do Outcomes Support Consensus Guidelines? (2010) (101)
- Ischemia-induced interleukin-8 release after human heart transplantation. A potential role for endothelial cells. (1995) (101)
- Transient normalization of systolic and diastolic function after support with a left ventricular assist device in a patient with dilated cardiomyopathy. (1996) (91)
- Ultrasonic Angioplasty in Totally Occluded Peripheral Arteries: Initial Clinical, Histological, and Angiographic Results (1991) (90)
- Potential of left ventricular assist devices as outpatient therapy while awaiting transplantation. (1994) (90)
- Selection criteria for placement of left ventricular assist devices. (1995) (89)
- The cost of medical management in advanced heart failure during the final two years of life. (2008) (88)
- Outpatient left ventricular assist device support: a destination rather than a bridge. (1996) (87)
- Long-term outcomes after cardiac transplantation: an experience based on different eras of immunosuppressive therapy. (2001) (84)
- Extended indications for lung volume reduction surgery in advanced emphysema. (1996) (84)
- Self-hypnosis reduces anxiety following coronary artery bypass surgery. A prospective, randomized trial. (1997) (83)
- Arginine vasopressin in the management of vasodilatory hypotension after cardiac transplantation. (1999) (83)
- Left ventricular assist device bridge-to-transplant network improves survival after failed cardiotomy. (1999) (82)
- Six-year experience of caring for forty-four patients with a left ventricular assist device at home: safe, economical, necessary. (2000) (82)
- Noncardiac Surgery in Long‐Term Implantable Left Ventricular Assist‐Device Recipients (1995) (82)
- Comparison of exercise performance in patients with chronic severe heart failure versus left ventricular assist devices. (1998) (80)
- Posttransplantation lymphoproliferative disorders treated with cyclophosphamide‐doxorubicin‐vincristine‐prednisone chemotherapy (1993) (80)
- Intravenous Pulse Administration of Cyclophosphamide Is an Effective and Safe Treatment for Sensitized Cardiac Allograft Recipients (2002) (77)
- Photochemotherapy in human heart transplant recipients at high risk for fatal rejection. (1992) (75)
- University of Wisconsin solution versus crystalloid cardioplegia for human donor heart preservation. A randomized blinded prospective clinical trial. (1992) (75)
- Is the Impact of Hospital and Surgeon Volumes on the In-Hospital Mortality Rate for Coronary Artery Bypass Graft Surgery Limited to Patients at High Risk? (2004) (75)
- Long-term survival after cardiac retransplantation: a twenty-year single-center experience. (1999) (74)
- Quantitative changes in T-cell populations after left ventricular assist device implantation: relationship to T-cell apoptosis and soluble CD95. (1999) (74)
- Surgical Management of Cardiac Pheochromocytoma Resection Versus Transplantation (1995) (74)
- Prophylactic photopheresis and chronic rejection: effects on graft intimal hyperplasia in cardiac transplantation (2000) (74)
- Relation between survival and development of coronary artery disease and anti-HLA antibodies after cardiac transplantation. (1989) (73)
- Intramyocardial Injection of Mesenchymal Precursor Cells and Successful Temporary Weaning From Left Ventricular Assist Device Support in Patients With Advanced Heart Failure: A Randomized Clinical Trial (2019) (73)
- Functional comparison of unilateral versus bilateral lung volume reduction surgery. (1997) (72)
- Heart transplantation in children with congenital heart disease. (1995) (71)
- Cost-effectiveness of coronary artery bypass surgery in octogenarians. (1998) (67)
- Experience with heart transplantation for cardiac tumors. (1995) (67)
- Risk stratification for coronary bypass surgery in patients with left ventricular dysfunction: analysis of the coronary artery bypass grafting patch trial database. (1999) (65)
- Single-stage management of sternal wound infections. (1990) (64)
- Impact of Current Management Practices on Early and Late Death in More Than 500 Consecutive Cardiac Transplant Recipients (2000) (62)
- The cost of long-term LVAD implantation. (2001) (62)
- Improved results for postcardiotomy cardiogenic shock with the use of implantable left ventricular assist devices. (1997) (62)
- De novo solid malignancies after cardiac transplantation. (1995) (62)
- An immunological algorithm to predict risk of high-grade rejection in cardiac transplant recipients (1998) (60)
- Fungal Infections in Left Ventricular Assist Device Recipients: Incidence, Prophylaxis, and Treatment (1995) (58)
- Management of lymphoproliferative disorders after cardiac transplantation. (1993) (57)
- Cardiac transplantation in children and adolescents. (1987) (57)
- Autologous fibrin glue from intraoperatively collected platelet-rich plasma. (1992) (56)
- Effect of Cerebral Embolic Protection Devices on CNS Infarction in Surgical Aortic Valve Replacement: A Randomized Clinical Trial (2017) (55)
- Safety and efficacy of aprotinin under conditions of deep hypothermia and circulatory arrest. (1995) (55)
- Primate cardiac allo-and xenotransplantation: modulation of the immune response with photochemotherapy. (1989) (54)
- Duration of left ventricular assist device support affects transplant survival. (1996) (54)
- Decreasing Incidence of Coronary Disease in Pediatric Cardiac Transplant Recipients Using Increased Immunosuppression (1993) (52)
- Prevention of retrosternal adhesion formation in a rabbit model using bioresorbable films of polyethylene glycol and polylactic acid. (1998) (52)
- Recurrent intravenous leiomyomatosis with cardiac extension. (1992) (52)
- Reduction of retrosternal and pericardial adhesions with rapidly resorbable polymer films. (1999) (48)
- Hemostatic effectiveness of fibrin glue derived from single-donor fresh frozen plasma. (1985) (48)
- Incidence of atrial fibrillation after mild or moderate hypothermic cardiopulmonary bypass (2000) (48)
- New strategies for early diagnosis of heart allograft rejection. (1997) (47)
- Effect of anti-HLA antibodies on the long-term survival of heart and kidney allografts. (1993) (46)
- Implantable left ventricular assist devices: an evolving long-term cardiac replacement therapy. (1997) (45)
- Late complications in pediatric cardiac transplant recipients. (1990) (44)
- Time-dependent cellular population of textured-surface left ventricular assist devices contributes to the development of a biphasic systemic procoagulant response. (1999) (44)
- Off-pump coronary-artery bypass surgery. (2003) (44)
- Asymptomatic Microembolism in Patients With Long‐Term Ventricular Assist Support (1996) (43)
- Indirect allorecognition of donor HLA-DR peptides in chronic rejection of heart allografts. (1998) (43)
- Recommendations of the National Heart, Lung, and Blood Institute Working Group on Future Direction in Cardiac Surgery. (2005) (42)
- Heparinless cardiopulmonary bypass with active-site blocked factor IXa: a preliminary study on the dog. (1998) (41)
- A Prospective Multi-Institutional Cohort Study of Mediastinal Infections After Cardiac Operations. (2017) (41)
- Selective anticoagulation with active site-blocked factor IXA suggests separate roles for intrinsic and extrinsic coagulation pathways in cardiopulmonary bypass. (1998) (41)
- Management of end-stage heart disease (1998) (40)
- Multivariate analysis of factors affecting waiting time to heart transplantation. (1996) (38)
- Immunologic monitoring in lung allograft recipients. (1996) (38)
- Factors affecting long-term survival (>10 years) after cardiac transplantation in the cyclosporine era. (2001) (38)
- Permanent pacing following cardiac transplantation. (1992) (37)
- Miniature axial flow pump for ventricular assistance in children and small adults. (1996) (36)
- Imaging of cardiac allograft rejection in dogs using indium-111 monoclonal antimyosin Fab. (1987) (35)
- University of Wisconsin solution for human donor heart preservation: initial clinical experience. (1991) (34)
- Utility of airway endoscopy in the diagnosis of respiratory complications of cardiac transplantation. (1988) (34)
- The Implantable Defibrillator: An Electronic Bridge to Cardiac Transplantation (1992) (34)
- Technique for Primate Heterotopic Cardiac Xenotransplantation (1985) (34)
- Preperitoneal Placement of Ventricular Assist Devices: An Illustrated Stepwise Approach (1995) (33)
- Anti-HLA antibodies and heart allograft survival. (1989) (33)
- Optimal timing of pediatric heart transplantation. (1989) (33)
- Pediatric heart transplantation after operations involving the pulmonary arteries. (1991) (32)
- Clinical experience with cardiac retransplantation. (1993) (32)
- Indirect recognition of native HLA alloantigens and B-cell help. (1995) (31)
- Evaluation of surgical procedures. Changing patterns of patient selection and costs in heart transplantation. (1992) (31)
- Increased early mortality in women undergoing cardiac transplantation. (1995) (31)
- The effects of self-hypnosis on quality of life following coronary artery bypass surgery: preliminary results of a prospective, randomized trial. (1995) (31)
- Destination mechanical circulatory support: proposal for clinical standards. (2003) (31)
- Anti-CD3 monoclonal antibody induction therapy. Immunological equivalency with triple-drug therapy in heart transplantation. (1990) (30)
- Transluminal aortic valve placement. A feasibility study with a newly designed collapsible aortic valve. (1996) (30)
- Mechanical cardiac support 2000: current applications and future trial design. June 15-16, 2000 Bethesda, Maryland. (2001) (29)
- Preservation of anterior leaflet chordae tendineae during mitral valve replacement. (1994) (29)
- Jugular Venous Bulb Oxyhemoglobin Saturation During Cardiac Surgery: Accuracy and Reliability Using a Continuous Monitor (1996) (29)
- Progress versus precision: challenges in clinical trial design for left ventricular assist devices. (2006) (29)
- History of mechanical circulatory support. (2000) (28)
- Cardiac xenotransplantation in primates. (1987) (28)
- Gastrointestinal Consequences of Left Ventricular Assist Device Placement (1996) (28)
- Pharmacologic antagonism of beta-adrenergic blockade in dogs. I. Hemodynamic effects of isoproterenol, dopamine, and epinephrine in acute propranolol administration. (1979) (28)
- Cerebral dysfunction after cardiac operations in elderly patients. (1995) (27)
- Wearable long-term mechanical support for patients with end-stage heart disease: a tenable goal. (1996) (27)
- Noncardiac surgery in heart transplant recipients in the cyclosporine era. (1991) (27)
- Primate animal model for the study of ABO incompatibility in organ transplantation. (1987) (27)
- Cerebral dysfunction after coronary artery bypass grafting done with mild or moderate hypothermia. (1997) (26)
- Sympathetic response during cardiopulmonary bypass: mild versus moderate hypothermia. (1997) (26)
- Orthotopic heart transplantation in patients with treated malignancies. (1995) (26)
- Discriminating between preservation and reperfusion injury in human cardiac allografts using heart weight and left ventricular mass. (1995) (25)
- Cardiac transplantation. Changing patterns in evaluation and treatment. (1985) (25)
- High-risk reparative surgery. A neglected alternative to heart transplantation. (1990) (25)
- Persistent allopeptide reactivity and epitope spreading in chronic rejection. (1998) (24)
- Improved heart preservation with University of Wisconsin solution: experimental and preliminary human experience. (1991) (24)
- The continuing evolution of mechanical ventricular assistance. (1997) (24)
- Single-stage treatment of sternal wound complications in heart transplant recipients in whom pectoralis major myocutaneous advancement flaps were used. (1995) (24)
- Cardiac transplantation after prolonged graft preservation with the University of Wisconsin solution. (1992) (24)
- Cytomegalovirus pneumonitis after cardiac transplantation. (1991) (24)
- Effect of recipient gender and race on heart and kidney allograft survival. (1992) (24)
- Secondary surgical‐site infection after coronary artery bypass grafting: A multi‐institutional prospective cohort study (2017) (23)
- Prophylactic photopheresis and effect on graft atherosclerosis in cardiac transplantation. (1995) (22)
- PROLONGATION OF PRIMATE CARDIAC XENOGRAFT SURVIVAL WITH CYCLOSPORINE (1987) (22)
- Respiratory complications of cardiac transplantation. (1988) (22)
- Left ventricular mechanics of counterpulsation and left heart bypass, individually and in combination. (1979) (21)
- Novel Preservation Solution Permits 24‐Hour Preservation in Rat and Baboon Cardiac Transplant Models (1993) (21)
- Reduced infection in cardiac transplant recipients. (1985) (21)
- The influence of concordant xenografts on the humoral and cell-mediated immune responses to subsequent allografts in primates. (1996) (20)
- Selective Anticoagulation With Active Site Blocked Factor IXa in Synthetic Patch Vascular Repair Results in Decreased Blood Loss and Operative Time (1997) (20)
- Inflow valve regurgitation during left ventricular assist device support may interfere with reverse ventricular remodeling. (1998) (20)
- Long-term function of human cardiac allografts assessed by two-dimensional echocardiography. (1989) (20)
- Patent foramen ovale complicating heart transplantation. A window on posttransplantation hemodynamics. (1987) (18)
- Exposure of the intramyocardial left anterior descending artery. (1994) (18)
- Adjustable annuloplasty for tricuspid insufficiency. (1987) (18)
- Evidence for unconscious memory processing during elective cardiac surgery. (1998) (17)
- TTP889, a Novel Orally Active Partial Inhibitor of FIXa Inhibits Clotting in Two A/V Shunt Models without Prolonging Bleeding Times. (2005) (17)
- Extending the limits of donor heart preservation: a trial with University of Wisconsin solution. (1991) (16)
- Reversal of cardiac transplant rejection without massive immunosuppression. (1986) (16)
- Additive value of immunologic monitoring to histologic grading of heart allograft biopsy specimens: implications for therapy. (1995) (15)
- Inhaled nitric oxide is not a myocardial depressant in a porcine model of heart failure. (1998) (15)
- Circulatory support with a direct cardiac compression device: a less invasive approach with the AbioBooster device. (2001) (14)
- Immunomodulation of kidney and heart transplants by anti-idiotypic antibodies. (1991) (14)
- Technique for removal of left ventricular assist devices. (1994) (14)
- Pediatric heart and heart-lung transplantation. (1991) (14)
- Role of indirect allorecognition in chronic rejection of human allografts. (1996) (14)
- Anti-idiotypic antibodies specific for HLA in heart and kidney allograft recipients (1993) (14)
- Cardiac xenograft survival in baboons treated with cyclosporine in combination with conventional immunosuppression. (1987) (13)
- Will atherosclerosis limit clinical xenografting? (1987) (13)
- Session IV: Surgical techniques in pediatric heart transplantation. (1991) (13)
- Bethesda Conference: conference for the design of clinical trials to study circulatory support devices for chronic heart failure. (1998) (13)
- Management of peripheral vascular problems in recipients of cardiac allografts. (1992) (13)
- Use of a pulsatile right ventricular assist device and continuous arteriovenous hemodialysis in a 57-year-old man with a pulsatile left ventricular assist device. (1995) (13)
- Comparable survival of intra-species and cross-species primate cardiac transplants. (1987) (12)
- Devices as destination therapy. (2003) (12)
- MARKED HYPOXEMIA AFTER GASTROPLASTY DUE TO DlSORDERS OF BREATHING IN RUM SLEEP (1987) (11)
- Characterization of mononuclear cell infiltrates in human cardiac allografts. (1984) (11)
- Soluble HLA and anti-idiotypic antibodies in transplantation: modulation of anti-HLA antibodies by soluble HLA antigens from the graft and anti-idiotypic antibodies in renal and cardiac allograft recipients. (1991) (11)
- Incidence of preformed antibodies against potential xenodonors in human sera. (1990) (11)
- Lymphocyte xenoantigens recognized by preformed antibodies. (1992) (11)
- Effect of simultaneous lung transplantation on heart transplant survival in rats. (1987) (10)
- Cardiac transplantation for endstage heart disease. (1997) (10)
- Immunomanipulation of the response to cardiac allo and xenoreactive leukocytes. (1989) (10)
- Indirect T-cell recognition in human allograft rejection. (1997) (10)
- Task force 6: Future developments (1993) (10)
- BETA‐ADRENERGIC RECEPTOR SENSITIVITY AND GUANINE NUCLEOTIDE REGULATORY PROTEINS IN TRANSPLANTED HUMAN HEARTS AND AUTOTRANSPLANTED BABOONS (1991) (10)
- Effect of anti-HLA and anti-idiotypic antibodies on the long-term survival of heart and kidney allografts. (1992) (10)
- Cost-Effectiveness of Mitral Valve Repair Versus Replacement for Severe Ischemic Mitral Regurgitation: A Randomized Clinical Trial From the Cardiothoracic Surgical Trials Network (2018) (9)
- Right ventricular obstruction in aortic dissection: a mechanism of hemodynamic collapse. (1996) (8)
- Prosthetic abdominal fascial closure after ventricular assist device insertion. (1995) (8)
- What is 'minimally invasive' coronary bypass surgery? Experience with a variety of surgical revascularization procedures for single-vessel disease. (1997) (8)
- Resurrection after mechanical circulatory support. (1997) (8)
- Serum dipeptidyl peptidase IV in cardiac transplant recipients. (1989) (8)
- Session VI: Rejection/infection: the limits of heart transplantation success. (1991) (8)
- Cyclosporine increases rat heart weight in heterotopic transplants. (1987) (8)
- Atrial septal dissection after mitral valve replacement demonstrated by transesophageal echocardiography. (1994) (8)
- Antagonism of chronic canine beta-adrenergic blockade with dopamine-isoproterenol, dobutamine, and glucagon. (1979) (8)
- Immunological monitoring of heart allograft recipients. (1987) (8)
- Role of the carrier solution in cyclosporine pharmacokinetics in the baboon. (1986) (7)
- Mechanical Unloading With a Miniature In‐Line Axial Flow Pump as an Alternative to Cardiopulmonary Bypass (1997) (7)
- The future of left ventricular assist device therapy in adults (2006) (7)
- Acquired coarctation of the aorta (1992) (6)
- Prophylactic EACA Administration Minimizes Blood Replacement Therapy (1994) (6)
- Mechanical and acoustic analysis in ultrasonic angioplasty (1991) (6)
- Non-surgical drainage of intra-abdominal and mediastinal abscesses: A report of twelve cases (2007) (6)
- Persistent allopeptide reactivity and epitope spreading in chronic rejection. (1999) (6)
- Sixteen years of cardiac transplantation: the Columbia Presbyterian Medical Center experience 1977 to 1993. (1993) (6)
- Ultrasonic Angioplasty in Totally Occluded Peripheral Arteries (2005) (6)
- Pretransplant blood transfusion in a primate cardiac xenograft model. (1987) (5)
- Cardiac transplantation for end-stage heart disease. (1999) (5)
- Renovascular hypertension following surgical repair of dissecting aneurysm of the thoracic aorta. (1978) (5)
- Simian-type blood group antigens in nonhuman primate cardiac xenotransplantation. (1987) (5)
- Massive air embolism with left ventricular assist device. (2002) (5)
- Incidence of malignancies in renal and cardiac transplant recipients in relation to treatment with biologic agents (1992) (5)
- Retrograde cardioplegia preserves myocardial function after induced coronary air embolism. (1997) (5)
- The Cardiothoracic Surgical Trials Network: Implications for clinical practice. (2017) (5)
- Colonic lymphoma as a cause of massive rectal bleeding in a cardiac transplant recipient. (1990) (5)
- FAILURE OF DONOR‐SPECIFIC PRETRANSPLANT BLOOD TRANSFUSION TO PROLONG HETEROTOPIC CARDIAC ALLOGRAFT SURVIVAL IN RATS (1987) (5)
- Imaging of cardiac transplantation rejection in primates using two new antimyosin agents. (1992) (4)
- Treatment of endstage heart disease with mechanical circulatory assistance. (1997) (4)
- Postoperative bone marrow injections with cyclosporine or antithymocyte globulin in rat cardiac allografts. (1986) (4)
- Limitations and clinical relevance of serial left ventricular mass determination by two-dimensional echocardiography: studies after orthotopic human cardiac transplantation (1988) (4)
- Indirect allorecognition in heart allograft rejection. (2001) (4)
- Mechanical circulatory support via the left ventricular vent: the concept of left ventricular copulsation. (1982) (4)
- Prolonged cardiac xenograft survival: a favorable comparison with allografts in primates. (1986) (4)
- Intravascular ultrasound imaging of the Heartmate 1000 IP left ventricular assist device. (1994) (4)
- A simplified method for the occlusion of the venae cavae during cardiopulmonary bypass. (1986) (4)
- Immunologic studies in primates undergoing concordant xenotransplantation as a bridge allotransplantation. (1996) (4)
- Use of the Abiomed BVS 5000 for temporary right ventricular assist following implantation of the TCI heartmate for left ventricular assist (1994) (3)
- Macaque-to-baboon cardiac transplantation: Model of choice for xenotransplantation in humans (1988) (3)
- 518: The VentrAssist LVAD as a Bridge to Cardiac Transplantation: Results of the U.S. Feasibility Trial (2008) (3)
- Importance of cell-mediated immune responses in rejection of concordant heart xenografts in primates. (1996) (3)
- Immunosuppression in cardiac transplantation. (1988) (3)
- Experimental Xenotransplantation Between Closely Related Primate Species (1991) (3)
- Cardiac allograft vasculopathy. (1995) (2)
- Effect of complete cardiac denervation on atrial natriuretic factor release in baboons. (1992) (2)
- Modern practices in cardiac transplantation (1988) (2)
- Role of cardiopulmonary bypass in single vessel coronary revascularization: implications for MID-CABG. (1998) (2)
- Innovation with experience using implantable left ventricular assist devices. (2009) (2)
- Anti-idiotypic antibodies regulate the immune response to HLA in heart allograft recipients. (1989) (2)
- 1987: Adjustable annuloplasty for tricuspid insufficiency. Updated in 1994. (1994) (2)
- Elimination of preformed antibody activity to xenoantigens utilizing dithiol-reducing agents. (1991) (2)
- system in patients awaiting heart transplantation Multicenter clinical evaluation of the HeartMate vented electric left ventricular assist (2006) (2)
- Pharmacologic antagonism of beta adrenergic blockade in dogs. II. Hemodynamic effects of simultaneous intravenous infusion of isoproterenol and dopamine during chronic propranolol administration. (1980) (2)
- Is the use of t-PA as compared with streptokinase cost effective? (1995) (2)
- CHANGING COST-EFFECTIVENESS OF LEFT VENTRICULAR ASSIST DEVICES AS DESTINATION THERAPY (2010) (2)
- Photochemotherapy provides donor-specific immunosuppression in cardiac transplantation (1990) (2)
- Bridging to cardiac transplantation: a clinical laboratory for the development of mechanical alternatives to transplantation. (1999) (1)
- Understanding translational research: a play in four acts. (2015) (1)
- Cardiac xenotransplantation: insurmountable barrier or clinical reality? (1994) (1)
- Self-MHC restricted T cells specific for donor peptides infiltrate human grafts during rejection. (1997) (1)
- External cardiac compression device supports circulation without compromising coronary artery bypass graft function (2000) (1)
- Xenograft cardiac transplantation: will it ever be a clinical reality? (1992) (1)
- 24th Bethesda conference: Cardiac transplantation. Task Force 6: Future developments. (1993) (1)
- A new continuous-flow LV assist device for patients with end-stage heart failure (2008) (1)
- Facilitated internal mammary artery anastomoses. (1993) (1)
- 916-87 Abiomed Ventricular Assist Device as a Bridge to Transplantation (1995) (1)
- Abstract 3376: The Outcomes and Costs of Intracorporeal and Extracorporeal Left Ventricular Assist Devices: An Analysis of the Centers for Medicare and Medicaid Services Database (2009) (1)
- New strategies to expand the donor pool: are they misguided? (2004) (1)
- Second Opinion: The Columbia-Presbyterian Guide to Surgery (2000) (1)
- Resection of giant benign fibrous mesothelioma of pleura. (1980) (1)
- SIX YEARS OF OUTPATIENT LEFT VENTRICULAR ASSIST DEVICE SUPPORT (1999) (1)
- Cardiac transplantation in children with congenital heart disease (1991) (1)
- Current Status of Cardiac Transplantation (1996) (0)
- Surgical Treatment of Ischemic Heart Disease in the Elderly (2003) (0)
- 15 Surgical Treatment of Ischemic Heart Disease in the Elderly (2003) (0)
- Adjustable huloplasty for Trimspid Insufficiency (1987) (0)
- INFLUENCE OF ABO BLOOD TYPE MATCHING ON SURVIVAL OF CARDIAC TRANSPLANT RECIPIENTS. (1999) (0)
- T&N Course Medicare Hot Topics for Nurses and Technicians (2015) (0)
- Feasibility Trial Results of the VentrAssist 3rd Generation LVAD for Bridge to Cardiac Transplantion (2007) (0)
- Accelerated atherosclerosis (1991) (0)
- Failure Inhaled Nitric Oxide Is Not A Myocardial Depressant In A Porcine Model Of Heart (2013) (0)
- Abstract 16962: Two-year Outcomes Following Mitral Valve Repair or Replacement for Severe Ischemic Mitral Regurgitation (2015) (0)
- ROLE OF AN ABIOMED FOR SHORT-TERM SUPPORT AND BRIDGE TO TRANSPLANTATION: THE COLUMBIA PRESBYTERIAN EXPERIENCE (2003) (0)
- Cardiac transplantation: future directions. (1992) (0)
- Patient Selection Criteria for Left Ventricular Assist Device Placement (1995) (0)
- ldiotypic Antibodies Specific for HLA in Heart and Kidney Allograft Recipients (0)
- SY-4-6 Surgical Treatment of Advanced Heart Failure : The Current Strategy at Columbia University : Improving Success With Heartmate Left Ventricular Assist Device As A Bridge To Transport (2004) (0)
- Elevated pulmonary vascular resistance and cardiac transplantation are larger donors better (1991) (0)
- Bud Frazier has pioneered mechanical circulatory support. (2014) (0)
- EVALUATION OF ALLOSPECIFIC T HELPER, T CYTOTOXIC AND T SUPPRESSOR CELLS IN TRANSPLANT RECIPIENTS.: Abstract# 358 (2000) (0)
- ORTHOTOPIC HEART AND HEART‐LUNG TRANSPLANTATION FOR LOCALLY ADVANCED CARDIAC TUMORS.: Abstract# 490 Poster Board #‐Session: P130‐II (2000) (0)
- Risks of cardiac transplantation. (1989) (0)
- INTRAOPERATTVE BISPECTRAL INDEX SCORES AND IMPLICIT MEMORY DURING CARDIAC SURGERY (2000) (0)
- THORACIC AND CARDIOVASCULAR SURGERY OFFICIAL PUBLICATION OF The American Association for Thoracic Surgery and The Western Thoracic Surgical Association (1995) (0)
- 2015 Medicare Update (2015) (0)
- Measurement of Jugular Venous Bulb Oxyhemoglobin Saturation and Cerebral Dysfunction in Patients Undergoing Cardiopulmonary Bypass at Moderate or Mild Hypothermia (1994) (0)
- Binding of preformed xenoantibodies to porcine bioprosthetic valves. (1991) (0)
- Cardiac xenotransplantation. (1990) (0)
- MESENCHYMAL PRECURSOR CELLS IN LVAD RECIPIENTS: DOES HF ETIOLOGY MAKE A DIFFERENCE? (2020) (0)
- Modernizing surgical education. (2002) (0)
- 342: The Epidemiology of Bleeding and Clotting in Pulsatile and Continuous Flow LVAD Patients (2008) (0)
- Long term, implantable ventricular assist devices: what are they and who needs them? (1995) (0)
- NONCARDIAC SURGERY IN HEART TRANSPLANT RECIPIENTS IN THE CYCLOSPORINE ERA (1988) (0)
- Two decades of cardiac transplantation at the Columbia-Presbyterian Medical Center: 1977-1997. (1996) (0)
- SURVIVAL AFTER HEART TRANSPLANTATION: ARE PRETRANSPLANT RISK FACTORS IMPORTANT? (1999) (0)
- Noninvasive imaging of cardiag transplantation rejection in primates using two new antimyosin imaging agents (1991) (0)
- Complex Calculations during Cardiopulmonary Bypass-1987 Technology (1997) (0)
- What's new in cardiac surgery. (1996) (0)
- Medicare Reimbursement Challenges (2015) (0)
- Heparinization during cardiopulmonary bypass. Simple calculator technique for control and reversal. (1980) (0)
- Benefits of Inhaled Nitric Oxide in Mitral Valve Surgery (1999) (0)
- Three Year Cumulative Experience with the VentrAssist Third Generation Left Ventricular Assist System (2006) (0)
- IS011 CURRENT CONCEPTS IN HEART TRANSPLANTATION (1997) (0)
- Treating ischemic disorder and improvement of the infarct-profit (1997) (0)
- Present status of human cardiac allografts and prospects for xenografts. (1988) (0)
- Adjustable annuloplasty for tricuspid insufficiency. (1989) (0)
- Cardiac Transplantation (1985) (0)
- Abstract 23239: Cost-Effectiveness of Repair versus Replacement for Severe Ischemic Mitral Regurgitation: A Randomized Clinical Trial From the Cardiothoracic Surgical Trials Network (2016) (0)
- BISPECTRAL INDEX AND MEMORY DURING CARDIAC SURGERY (1999) (0)
- Does the time between ventricular assist device implantation and heart transplantation affect survival? (2004) (0)
- Long-Term Survival After Cardiac Retransplantation: A Twenty-Year Single-Center (2013) (0)
- Clinical Characteristics and Outcomes of Patients Supported with Left Ventricular Assist Devices: Are Bridge-to-Transplant and Destination Therapy Populations Different? (2006) (0)
- Predictingrecurrentmitralregurgitationaftermitralvalverepairfor severe ischemic mitral regurgitation (2015) (0)
- Clinical Investigations The Cost of Medical Management in Advanced Heart Failure During the Final Two Years of Life (2008) (0)
- Role of immune response genes in anti-HLA antibody production in heart allograft recipients (1992) (0)
- Treatment of an ischemical disorder and improvement of the consequences of a cerebrovascular accident. (1997) (0)
- A162 Evidence for implicit memory cardiac surgery (1997) (0)
- Mechanical circulatory support via the left ventricular vent the concept of co pulsation (1979) (0)
- Implantable circulatory assistance and the kidney (1998) (0)
- Cardiac Transplantation in Small Children (1986) (0)
- SYMPATHETIC RESPONSE TO MILD AND MODERATE HYPOTHERMIC CARDIOPULMONARY BYPASS (1995) (0)
- Heart allograft survival in outbred dogs treated with procarbazine hydrochloride and antithymocyte globulin. (1985) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Eric A. Rose?
Eric A. Rose is affiliated with the following schools:
